Académique Documents
Professionnel Documents
Culture Documents
destruction of beta cells, do not produce insulin, and are prone to ketoacidosis.
These cases are referred to as fulminant T1DM (Nelms, Sucher, & Lacey, 481).
3. What genes have been identified that indicate susceptibility to type 1 diabetes
mellitus?
Multiple genes have been identified that indicate susceptibility to type 1 diabetes
mellitus. Nelms, Sucher, and Lacey identify the primary gene for type 1 DM to be
located in the HLA region on chromosome 6. They also indicate that
polymorphisms in the HLA complex account for 40%-50% of the genetic risk of
developing type 1 DM, but more than 20 different gene associations have been
linked to risk for this disease (481). Van Belle, Coppieters, and Von Herrath refer to
this gene as IDDM1, for insulin-dependent diabetes mellitus locus. They also
identify a lesser predisposition to the insulin gene. This gene is referred to as
IDDM2 on chromosome 11 containing the insulin gene region. In addition, they
identify a relatively new member of the T1D susceptibility gene set is PTPN22,
which encodes the lymphoid protein tyrosine phosphatase (LYP), Allelic variation
in the interleukin (IL)-2 receptor- gene (IL2RA) region, which is an essential
molecule expressed on T cells upon activation and on natural Tregs at baseline, and
lastly the gene encoding cytotoxic T lymphocyte-associated protein 4 (CTLA-4) in
the IDDM12 region, which is by all accounts a vital molecule for proper negative
regulation of immune responses (Van Belle, Coppieters, and Von Herrath, 2011).
4. After examining Susans medical history, can you identify any risk factors for type 1
DM?
Susan has had an uneventful medical history with no significant illness until the past
several weeks, but there is a history of diabetes in the family from her maternal
grandmother. Her young age may also increase her risk for developing type 1 DM.
5. What are the established diagnostic criteria for type 1 DM? How can the physicians
distinguish between type 1 and type 2 DM?
There are four main criteria for the diagnosis of diabetes mellitus. An individual can
be diagnosed for diabetes if they meet any one of the four criteria. These include a
hemoglobin A1c of greater than or equal to 6.5% using standardized laboratory
measures, or a fasting plasma glucose level of greater than or equal to 126 mg/dL
(7.0 mmol/L), or symptoms of diabetes plus a random plasma glucose concentration
of greater than or equal to 200 mg/dL (11.1 mmol/L), or a 2-hour post-prandial
glucose level of greater than or equal to 200 mg/dL (11.1 mmol/L) during an oral
glucose tolerance test (OGTT) (Nelms, Sucher, & Lacey, Box 17.2, 481). Physicians
distinguish between type 1 and type 2 DM based on the individuals insulin status.
Beta cell destruction with absolute insulin deficiency indicates type 1 DM while
progressive defective insulin secretion with insulin resistance indicates type 2 DM
(Nelms, Sucher, & Lacey, Box 17.1, 480). Key indicators of type 1 DM may include
the presence of autoantibodies in the blood that are common in type 1 DM (Islet cell
autoantibodies, Glutamic Acid Decarboxylase autoantibodies, and Insulin
autoantibodies) or the presence of ketones in the urine that indicate the bodys
breakdown of fat (Mayo Clinic, 2014).
6. Describe the metabolic events that led to Susans symptoms (polyuria, polydipsia,
polyphagia, weight loss, and fatigue) and integrate these with the pathophysiology of
the disease.
When the bodys pancreatic beta cells are destroyed and insulin production ceases,
glucose cannot enter the cells. This causes hyperglycemia and cells begin to starve.
As a result of this, gluconeogenesis is increased in the liver and glycogenolysis is
stimulated and further contributes to the hyperglycemic state. Because the kidneys
can only filter so much glucose from the blood, excess glucose is lost in the urine,
resulting in glycosuria and polyuria. Glycosuria is the presence of glucose in the
urine while polyuria is frequent urination. This loss of fluid leads to polydipsia,
which describes excessive thirst. Polyphagia, or excessive hunger, is then initiated
due to the cells lack of glucose to use as energy. The body then begins to break
down fat stored in adipose tissue to use as energy. This results in weight loss and
the production of ketone bodies that are secreted in the urine. The ketoacidosis that
results from the breakdown of fat will cause the body to have deep, labored
respirations, called Kussmaul respirations, in an effort to offset this metabolic
acidosis. This, along with the many other symptoms previously listed, may
contribute to Susans fatigue. (Nelms, Sucher, & Lacey, 481)
7. List the microvascular and neurologic complications associated with type 1
diabetes.
Cardiovascular Disease (Nelms, Sucher, & Lacey, 507)
Hyperglycemia makes blood vessels prone to endothelial damage,
causing thickening and decreased flexibility of the vessels and
increased high blood pressure.
Hypertension is a risk factor for cardiovascular disease as well as a
complication for microvascular complications such as retinopathy and
nephropathy.
8. When Susans blood glucose level is tested at 2 AM, she is hypoglycemic. In addition,
her plasma ketones are elevated. When she is tested early in the morning before
breakfast, she is hyperglycemic. Describe the dawn phenomenon. Is Susan likely to be
experiencing this? How might this be prevented?
Nelms, Sucher, and Lacey define the dawn phenomenon as an increase in blood
glucose in the early morning, most likely due to increased glucose production in the
liver after an overnight fast (470). If Susan is hypoglycemic at 2 AM, but
hyperglycemic before breakfast, she is likely experiencing the dawn phenomenon as
a result of her overnight fast. The dawn phenomenon is a result of hormones
involved in controlling circadian rhythms. Gluconeogenesis is stimulated by cortisol
and growth hormone, which causes hyperglycemia between 5 AM and 9 AM (Nelms,
Sucher, & Lacey, 505). This may be prevented by having bedtime snacks or
adjusting insulin regimens.
9. What precipitating factors may lead to the complication of diabetic ketoacidosis?
List these factors and describe the metabolic events that result in the signs and
symptoms associated with DKA.
II.
Risk factors:
Risk for DKA is highest during illness, infection, and emotional stress.
Omission of insulin, due to illness or infection and fear of
hypoglycemia, is a frequent cause of DKA. (Nelms, Sucher, & Lacey,
505)
Pathophysiology:
When insulin is not available for the cells to take in glucose, glucose is
produced via gluconeogenesis and lipolysis. Lipolysis, or the
breakdown of fat for energy, generates ketones that accumulate in the
bloodstream causing osmotic diuresis, dehydration, and electrolyte
imbalances. The blood becomes concentrated as fluid is lost, further
contributing to hyperglycemia. (Nelms, Sucher, & Lacey, 505)
Symptoms:
Nausea and/or vomiting
Stomach pain
Fruity or acetone breath
Kussmaul respirations
Mental status changes
(Nelms, Sucher, & Lacey, 505)
Nutrition Assessment
which is why she was estimated to need 1.2 grams of protein per kilogram of body
weight rather than the usual 0.8 grams of protein per kilogram of body weight.
13. What would the clinician monitor in order to determine whether or not the
prescribed energy level is adequate?
The clinician would need to monitor her weight to ensure she is maintaining her
currently healthy weight and discontinuing her weight loss. If Susan feels she is
continuing to lose weight, an increase in calories may be necessary. It would also be
beneficial to monitor any changes in Susans activity level, for example when
volleyball is in season versus out of season. Susans estimated energy and protein
requirements were calculated to take into account her participation in sports, but if
that changes, her energy and protein needs would need to be recalculated to reflect
her decrease in daily physical activity. Failure to take this into account could result
in excess calorie and protein intake and ultimately, weight gain.
C. Intake Domain
14. Using a computer dietary analysis program or food composition table, calculate
the kcalories, protein, fat (saturated, polyunsaturated, and monounsaturated), CHO,
fiber, and cholesterol content of Susans typical diet.
Meal
AM
Food Item
kcal
Pro
(g)
Fat
(g)
CHO
(g)
Fiber
(g)
Chol
(mg)
1 c dry cereal
(Frosted flakes)
232
3.06
2.1
S- 1.56
M- 0.36
P- 0.12
51.06
0.8
1 c 2% milk
137
9.68
4.85
S- 3.1
M- 1.38
P- 0.18
13.45
20
1 c orange juice
117
1.69
0.37
S- 0.05
M- 0.06
P- 0.08
27.41
0.7
1 c hot chocolate
(made with water)
80
0.6
3
S- 2
M- 0
P- 0
15
0.8
Lunch
Snack
PM
6 in pepperoni pizza
1,042
47.84
42.33
S- 19.2
M- 14.9
P- 7.57
117.37
6.3
97
1 c mixed salad
0.58
0.14
S- 0.02
M- 0.01
P- 0.08
1.55
c Thousand Island
dressing
119
0.51
6.93
S- 0.46
M- 3.96
P- 1.65
14.74
0.7
1 can Coke
155
0.92
S- 0
M- 0
P- 0
38.33
280
4.29
13.59
S- 5.17
M- 4.49
P- 1.72
35.06
1.3
252
0.01
4.59
S- 1.17
M- 1.17
P- 1.17
45.18
1.4
56
0.03
0
S- 0
M- 0
P- 0
14.69
0.2
283
11.55
23.97
S- 3.65
M- 11.1
P- 6.69
10.35
3.8
12 oz can of Coke
155
0.92
S- 0
M- 0
P- 0
38.33
2 c spaghetti noodles
477
17.52
2.81
S- 0.53
93.2
5.4
M- 0.40
P- 0.99
HS snack
Totals:
c spaghetti sauce
66
1.83
2.13
S- 0.29
M- 0.39
P- 0.89
9.81
2.4
1 oz ground beef
71
7.35
4.37
S- 1.63
M- 2.13
P- 0.18
25
3 stalks steamed
broccoli w/ cheese
sauce
299
17.08
10.58
S- 3.98
M- 2.49
P- 2.21
43.07
18.1
18
16 oz 2% milk
274
19.36
9.7
S- 6.18
M- 2.76
P- 0.36
26.9
39
2 c ice cream
558
9.64
29.04
S- 17.9
M- 8.16
P- 1.14
68.37
2.5
103
12 oz Coke
155
0.92
S- 0
M- 0
P- 0
38.33
4,816
152.62
163.26
S- 66.89
M- 53.76
P- 25.03
702.2
45.4
320
15. What dietary assessment tools can Susan use to coordinate her eating patterns
with her insulin and physical activity?
Susan can monitor her progress using self-monitoring records and laboratory tests.
These will assess whether or not she is effectively coordinating her eating patterns
with her insulin and physical activity. Self-monitoring blood glucose (SMBG) can
Clinical data
Nutrition history
1. 24-hour recall
2. Dietary intake journal
3. Food preferences, allergies, or
intolerances
Weight history
1. Current weight
2. % Usual body weight
3. BMI (BMI-for-age percentile)
Monitoring
D. Clinical Domain
17. Does Susan have any laboratory results that support her diagnosis?
Susan has four abnormal laboratory values that support her diagnosis. Her
osmolality levels were high both at admit (304 mmol/kg/H20) and at d/c (297
mmol/kg/H20). This indicates that Susan was dehydrated, most likely as a result of
her hyperglycemia and related polyuria. Susans glucose levels were extremely high
at admit (250 mg/dL) and moderately high at d/c (120 mg/dL). This is the most
obvious indicator of her type 1 DM. If glucose is building up in her blood, this means
it isnt being used by her cells. Her cells need insulin to use glucose so if they arent
using the glucose, she is lacking insulin. Her BUN levels were slightly high at admit
(20 mg/dL) and in the upper range of normal at d/c (18 mg/dL). The presence of
increased nitrogen in her urine indicates that her kidneys are not working properly.
Diabetes can cause nephropathy, which describes damaged nerves and blood
vessels in the kidneys that cause them to work less efficiently. Lastly, Susans HbA1c
was high at admit (7.95%). This indicates that over the past three months, Susans
blood glucose levels were high (about 183 mg/dL on average). This constant
hyperglycemia supports her diagnosis of type 1 DM. Susan also had a slightly high
prealbumin level at admit (40 mg/dL) and d/c (39 mg/dL). This could simply be due
to her diet and shouldnt be of serious concern until her prealbumin levels fall below
normal levels. This could, however, indicate that there is decreased kidney function,
which would be supported by her high BUN levels.
18. Why did Dr. Green order a lipid profile?
Dr. Green ordered a lipid profile to evaluate Susans LDL cholesterol, HDL
cholesterol, and triglyceride levels. An abnormal lipid profile could indicate diabetic
dyslipidemia. Several factors are likely to be responsible for diabetic dyslipidemia:
insulin effects on liver apoprotein production, regulation of lipoprotein lipase (LpL),
actions of cholesteryl ester transfer protein (CETP), and peripheral actions of insulin
on adipose and muscle (Endocrine Society, 2013). Along with blood pressure
monitoring, Susans lipid profile should be monitored annually, or as frequently as
needed, and the accuracy of these tests are dependent on an overnight fast. Susans
goal values are an LDL cholesterol level of <100 mg/dL, an HDL cholesterol level of
>50 mg/dL, and a triglyceride level of <150 mg/dL (Nelms, Sucher, & Lacey, 504).
Abnormal lipid levels could also indicate that Susan needs to make lifestyle
adjustments, such as her diet, physical activity, or use of insulin for glucose
monitoring. Dr. Green may also be looking to see if Susan is using glucose as energy
or if she is burning fat.
19. Evaluate Susans laboratory values:
Chemistry
Prealbumin
(mg/dL)
Osmolality
(mmol/kg/H20)
Normal
Value
Nutritional
Implications
16-35
40
39
Susan is receiving
adequate calories and
protein and is not
experiencing
malnutrition.
285-295
304
297
May require
increased fluid needs
until returned to
normal range, but
will adjust once
hyperglycemia is
controlled.
Glucose (mg/dL)
BUN (mg/dL)
HbA1c (%)
70-110
250
120
Glucose is building up in
her blood because there
is insufficient insulin to
allow the cells to use
glucose as energy.
Use of insulin to
adjust alterations in
glucose levels caused
by carbohydrate
intake, exercise,
stress, etc. Requires
carbohydrate
counting and close
diet monitoring.
8-18
20
18
Requires adequate
fluids and
electrolytes. May also
require reduced
protein intake until
diabetes is controlled
to give the kidneys
time to do less work
and repair.
3.9-5.2
7.95
Hyperglycemia due to
lack of insulin consistent
with type 1 DM. Over the
past three months,
Susans blood glucose
levels were high (about
183 mg/dL on average).
Same as nutritional
implications for
glucose. Once daily
glucose is controlled,
so will mean glucose
over 2-3 months.
Brand Name
Onset of
Action
Peak of Action
Duration of
Action
lispro
Humalog
5-15 minutes
30-90 minutes
3-5 hours
aspart
Novolog
5-15 minutes
30-90 minutes
3-5 hours
glulisine
Apidra
5-15 minutes
30-90 minutes
3-5 hours
NPH
Humulin N
Novolin N
2-4 hours
4-10 hours
10-18 hours
glargine
Lantus
2-4 hours
Peakless
20-24 hours
detemir
Levemir
1-3 hours
6-8 hours
18-22 hours
70/30 premix
Humulin 70/30
Novolin 70/30
30-60 minutes
Dual
10-16 hours
5-15 minutes
Dual
10-16 hours
50/50 premix
10-15 minutes
Varies
10-16 hours
60/40 premix
Mixtard 40
30 minutes
2-8 hours
24 hours
23. Just before Susan is discharged, her mother asks you, My friend who owns a health
food store told me that Susan should use stevia instead of artificial sweeteners or
sugar. What do you think? What will you tell Susan and her mother?
Stevia, also known as Rebaudioside A or rebiana, is generally recognized as safe by
the Food and Drug Administration as a food additive and a table-top sweetener.
Stevia is a non-caloric plant-based sweetener that is hundreds of times sweeter than
sugar. This allows individuals to use much less sweetener, but Stevia may affect
different individuals in various ways. There are many different opinions on the
effect Stevia may have on individuals with diabetes, so the only way to decide if
Stevia is right for you is to try it out! When trying Stevia, it is important to
constantly monitor your blood glucose levels to ensure that it does not negatively
affect these values. It is also important to note any physical changes, such as
lightheadedness, nausea, or any other symptoms that may indicate a change in
blood sugar. This may mean you have to adjust the amount of Stevia you are using,
or that you should discontinue the use of Stevia altogether. Artificial sweeteners
have more research on their safety and side effects so it may be easier to decide to
use these products.
F. Nutrition Diagnosis
24. Select two high-priority nutrition problems and complete the PES statement for
each.
Self-monitoring deficit (NB-1.4) related to food- and nutrition-related
knowledge deficit concerning self-monitoring as evidenced by a new medical
diagnosis of type 1 diabetes mellitus, no self-management equipment, a
blood glucose level of 250 mg/dL at admit, and a hemoglobin A1c of 7.95%.
Excessive carbohydrate intake (NI-5.8.2) related to physiological causes
requiring moderate carbohydrate intake (type 1 diabetes mellitus) as
evidenced by a blood glucose level of 250 mg/dL at admit, a hemoglobin A1c
of 7.95%, and a usual diet recall indicating an intake of 702 grams of
carbohydrate.
III.
Nutrition Intervention
25. For each of the PES statements that you have written, establish an ideal goal
(based on the signs and symptoms) and an appropriate intervention (based on the
etiology).
The ideal goal for Susans self-monitoring of her blood glucose would be to
lower her blood glucose levels to the normal range of 70-110 mg/dL. This
will also reduce her hemoglobin A1c to the normal range of 3.9-5.2%. In
order to achieve this goal, an appropriate intervention would be to educate
Susan on self-monitoring techniques common with type 1 diabetes mellitus.
This would include carbohydrate counting, insulin injections, insulin pumps,
and the effect of diet, physical activity, stress, and other lifestyle factors on
blood glucose levels and the need for insulin. In addition to these education
sessions, it would be useful for Susan to keep a self-monitoring/diet/physical
activity journal that would be reviewed in follow-up counseling sessions.
These sessions would continue two to three times per month until Susan felt
comfortable enough with her diabetes regimen to space out her sessions over
longer periods of time. She would also need frequent laboratory tests and
meetings with her physician to ensure her laboratory values are within their
normal ranges.
Susan is not necessarily at fault for her excess carbohydrate intake because
she had no knowledge of her type 1 diabetes mellitus diagnosis up until this
hospital visit. Now that she is aware of her diagnosis, the ideal goal for her
excessive carbohydrate intake would be to reduce her intake to about 300
grams per day. This value is reflected in her current diet order, which is
consistent with the values I have calculated. Her usual diet recall indicates
that she is consuming about 702 grams of carbohydrate per day and this is
resulting in a consistently elevated blood glucose level, reflected in her
hemoglobin A1c of 7.95%. In order for Susan to consciously reduce or control
her intake of carbohydrates, she must be educated on the carbohydrate
content of food items, the types of carbohydrates, and how they affect her
blood glucose levels. As long as Susan learns to administer the proper
amount of insulin to compensate for her carbohydrate consumption every
time she eats, she should be able to easily control her dietary blood glucose
levels.
26. Does the current diet order meet Susans overall nutrition needs? If yes, explain
why it is appropriate. If no, what would you recommend? Justify your answer.
The current diet order does meet Susans overall nutrition needs. The current diet
order suggests that Susan intake 2,400 kilocalories per day, 300 grams of
carbohydrate per day, 55-65 grams of protein per day, and 80 grams of lipid per
day. Susans estimated energy requirements were calculated in question #12 to be
about 2,407 kilocalories per day, using a physical activity factor of 2.0 to account for
her being a volleyball player. Susan should be getting about 45% of her kilocalories
References
Centers for Disease Control and Prevention. (2009). Clinical growth charts.
Retrieved from http://www.cdc.gov/growthcharts/clinical_charts.htm
Centers for Disease Control and Prevention. (2015). Defining childhood obesity.
Retrieved from http://www.cdc.gov/obesity/childhood/defining.html
Endocrine Society. (2013). Diabetic dyslipidemia: Causes and consequences.
Retrieved from http://press.endocrine.org/doi/full/10.1210/jcem.86.3.7304
Mayo Clinic (2014). Type 1 diabetes. Retrieved from
http://www.mayoclinic.org/diseases-conditions/type-1diabetes/basics/tests-diagnosis/con-20019573
National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.) Insert c:
Types of insulin. Retrieved from http://www.niddk.nih.gov/healthinformation/health-topics/Diabetes/diabetesmedicines/Pages/insert_C.aspx
Nelms, M., Sucher, K.P., & Lacey, K. (2014). Nutrition therapy and pathophysiology.
Boston, MA: Cengage Learning.
Van Belle, T.L, Coppieters, K.T., & Von Herrath, M.G. (2011). Type 1 diabetes:
Etiology, immunology, and therapeutic strategies. Physiological Reviews, 91
(1), 79-118. doi: 10.1152/physrev.00003.2010.